[go: up one dir, main page]

FR2976286B1 - 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent - Google Patents

4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent

Info

Publication number
FR2976286B1
FR2976286B1 FR1101747A FR1101747A FR2976286B1 FR 2976286 B1 FR2976286 B1 FR 2976286B1 FR 1101747 A FR1101747 A FR 1101747A FR 1101747 A FR1101747 A FR 1101747A FR 2976286 B1 FR2976286 B1 FR 2976286B1
Authority
FR
France
Prior art keywords
same
hexahydrocyclopenta
pyrrol
benzamide
propoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1101747A
Other languages
English (en)
Other versions
FR2976286A1 (fr
Inventor
Alain Dhainaut
Anne Marie Chollet
Patrick Casara
Pierre Lestage
Fany Panayi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Priority to FR1101747A priority Critical patent/FR2976286B1/fr
Priority to PCT/FR2012/051287 priority patent/WO2012168664A1/fr
Publication of FR2976286A1 publication Critical patent/FR2976286A1/fr
Application granted granted Critical
Publication of FR2976286B1 publication Critical patent/FR2976286B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1101747A 2011-06-08 2011-06-08 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent Expired - Fee Related FR2976286B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1101747A FR2976286B1 (fr) 2011-06-08 2011-06-08 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent
PCT/FR2012/051287 WO2012168664A1 (fr) 2011-06-08 2012-06-08 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl] propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1101747A FR2976286B1 (fr) 2011-06-08 2011-06-08 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent

Publications (2)

Publication Number Publication Date
FR2976286A1 FR2976286A1 (fr) 2012-12-14
FR2976286B1 true FR2976286B1 (fr) 2013-05-24

Family

ID=44508420

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1101747A Expired - Fee Related FR2976286B1 (fr) 2011-06-08 2011-06-08 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent

Country Status (2)

Country Link
FR (1) FR2976286B1 (fr)
WO (1) WO2012168664A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2647377A1 (fr) 2012-04-06 2013-10-09 Sanofi Utilisation d'un antagoniste du récepteur h3 pour le traitement de la maladie d'Alzheimer
WO2015032966A1 (fr) * 2013-09-09 2015-03-12 Sanofi Antagoniste des récepteurs h3 combiné à un inhibiteur de la cholinestérase et utilisé dans le cadre du traitement de la maladie d'alzheimer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2937251B1 (fr) * 2008-10-16 2011-03-18 Servier Lab Utilisation du 4-{3-°hexahydrocyclopenta°c!pyrrol-2(1h)-yl! propoxy}benzamide pour l'obtention de medicaments destines au traitement des troubles du sommeil

Also Published As

Publication number Publication date
WO2012168664A1 (fr) 2012-12-13
FR2976286A1 (fr) 2012-12-14

Similar Documents

Publication Publication Date Title
HK1259355A1 (zh) 作為btk激酶抑制劑的2，3-二氫異吲哚-1-酮衍生物、以及含有所述衍生物的藥物組合物
ZA201208198B (en) Picolinamide and pyrimidine-4-carboxamine compounds, process for preparing and pharmaceutical composition comprising the same
FR2986002B1 (fr) Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IL231226A (en) Compounds and preparations as kinase c-kit inhibitors, pharmaceutical preparations containing them and their use in the preparation of medicines for the treatment of diseases
PL2661180T3 (pl) Mieszanka zawierająca ciepłochwiejne białka mleka i sposób jej przygotowania
AP3104A (en) New association between 4-{3-[CIS-hexahydrocyclopenta[c]pyrrol-2(1H)-YL]propoxy}benzamide and an Acetylcholinesterase inhibitor, and pharmaceutical compositions containing it
EP2742020A4 (fr) Dérivé de biguanide à substitution n1-amine cyclique-n5, procédés de préparation associés et composition pharmaceutique les comprenant
EP2697238A4 (fr) Formes solides de composés antirétroviraux, procédé de préparation correspondant et composition pharmaceutique de ces composés
HRP20181326T1 (hr) Pesticidni pripravak i postupak za njegovu proizvodnju
ZA201309559B (en) Comptothecin derivative, method for preparing same, pharmaceutical composition and use thereof
HK1209426A1 (zh) 培美曲塞及其賴氨酸鹽的製備方法
IL225105A (en) Heterocyclic compounds, their process, their pharmaceutical preparations and their use in the preparation of drugs
FR2973037B1 (fr) Adhesifs structuraux, procede pour leur preparation, et leur application
ZA201209674B (en) Pharmaceutical compositions comprising paracetamol and process for preparing the same
PL2532651T3 (pl) Sposób syntezy i postać krystaliczna chlorowodorku 4-{3-[cis-heksahydrocyklopenta[c]pirol-2(1h)-ilo]propoksy} benzamidu i jego wolnej zasady oraz kompozje farmaceutyczne je zawierające
IL236437A (en) Acrylamide compounds as histamine h3 receptor ligands, process for preparation, medicinal preparations containing them and their uses
AP3225A (en) New combination between 4-{3-[CIS-hexahydrocyclopenta[C]pyrrol-2(1H)-yl]propoxy}benzamide and an NMDA receptor antagonist, and pharmaceutical compositions containing it
FR2976286B1 (fr) 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent
FR2980136B1 (fr) Composites, leur procede de preparation et les voiles de vol les comprenant
PL399613A1 (pl) Pochodne estrów diarylowych kwasów 1-aminoalkanofosfonowych, sposób wytwarzania pochodnych estrów diarylowych kwasów 1-aminoalkanofosfonowych oraz ich zastosowanie
FR2972454B1 (fr) Nouveaux derives dihydro-oxazolobenzodiazepinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2992218B1 (fr) Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
FR2964969B1 (fr) Nouveaux derives dihydrobenzoxathiazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PT2802558T (pt) Compostos com atividade antibacteriana, processo para a sua preparação, e composições farmacêuticas compreendendo os mesmos
FR2987301B1 (fr) Procede de preparation d'un materiau biocomposite.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20150227